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Summary Statement: During lung alveolar development Glucocorticoid Receptor and STAT3 
signalling act in parallel, but cross-regulated, pathways to promote epithelial differentiation. 
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 SUMMARY 
Insufficient alveolar gas exchange capacity is a major contributor to lung disease. During lung 
development, a population of distal epithelial progenitors first produce bronchiolar-fated and 
subsequently alveolar-fated progeny. The mechanisms controlling this bronchiolar to alveolar 
developmental transition remain largely unknown. We developed a novel grafting assay to test if 
lung epithelial progenitors are intrinsically programmed or if alveolar cell identity is determined 
by environmental factors. These experiments revealed that embryonic lung epithelial identity is 
extrinsically determined. We show that both glucocorticoid and STAT3 signalling can control the 
timing of alveolar initiation, but that neither pathway is absolutely required for alveolar fate 
specification; rather, glucocorticoid receptor and STAT3 work in parallel to promote alveolar 
differentiation. Thus, developmental acquisition of lung alveolar fate is a robust process 
controlled by at least two independent extrinsic signalling inputs. Further elucidation of these 
pathways may provide therapeutic opportunities for restoring alveolar capacity. 
 
INTRODUCTION 
The gas exchange capacity of the lung is determined by its functional alveolar surface area. 
During mouse lung development the early phase (pseudoglandular ~E12.5–15.5) of branching 
morphogenesis has been mapped in great detail and produces the bronchiolar (conducting airway) 
tree (Short et al., 2013). During later morphogenesis (canalicular stage ~E16.5-17.5), although 
the pattern is less well-defined, branching continues to produce the framework for future alveolar 
development (Alanis et al., 2014). The final size of the gas exchange surface is therefore likely to 
be strongly influenced by the extent of morphogenesis in the canalicular phase of lung 
development. Defining the mechanisms which control the developmental transition between 
bronchiolar and alveolar morphogenesis may ultimately permit manipulation of the size of the 
alveolar surface for therapeutic purposes. 
 
Definitive lineage-tracing experiments have shown that during lung development the distal tip 
epithelial cells comprise a multipotent progenitor population (Alanis et al., 2014; Desai et al., 
2014; Rawlins et al., 2009a). Tip progenitors are defined by a specific molecular signature, 
including high levels of SOX9 and ID2. During the pseudoglandular stage their descendants exit 
the distal tip as SOX2+ bronchiolar progenitors and from ~E16.5, during the canalicular stage, 
their descendants leave the distal progenitor pool as SOX2- alveolar progenitors. Distal 
progenitors persist at the edge of the lungs until late E17.5/early E18.5, after which tip structures 
can no longer be detected. Recent molecular experiments have shown that from ~E16.5 distal 
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 progenitors express low levels of markers of both type I and II alveolar epithelial cells (AT1 and 
AT2) (Desai et al., 2014; Treutlein et al., 2014). Maturation of AT1 and 2 cells likely occurs as 
SOX2- alveolar progenitors down-regulate markers of one lineage whilst up-regulating those of 
the other. 
 
It has been known for many years that glucocorticoid signalling can promote maturation of 
alveolar cells into functional AT1 and 2 cells. Glucocorticoid Receptor (Nr3c1, here GR) null 
lungs produce fewer AT1 and 2 cells and synthetic glucocorticoids are routinely used to promote 
alveolar maturation in infants at risk of premature birth (Cole et al., 2004). A recent study showed 
that precocious administration of glucocorticoid during mouse lung development promotes the 
transition from bronchiolar to alveolar fate in the distal progenitors. Moreover, alveolar initiation 
was delayed in GR-/- mutant lungs, resulting in an extra round of bronchiolar branching (Alanis et 
al., 2014). Hence GR-mediated signalling controls the timing of alveolar initiation. However, GR 
signalling is not absolutely necessary for distal progenitor alveolar fate, or alveolar differentiation, 
and additional mechanisms must also regulate these processes. 
 
To establish whether an intrinsic mechanism or external factors trigger the bronchiolar to alveolar 
developmental transition during normal development, we developed a heterochronic grafting 
assay. These experiments showed that non-cell autonomous signalling plays a major role in 
determining progeny fate of SOX9+ distal tip cells. We investigated the underlying molecular 
mechanisms and present evidence that STAT3 and GR act in parallel during lung alveolar 
initiation and are individually sufficient to promote alveolar differentiation.  
 
RESULTS 
Expression of alveolar-fate markers during mouse lung embryonic development 
It was recently reported that alveolar gene expression begins in distal tip epithelial progenitors 
before overt morphological signs of alveolar differentiation (Desai et al., 2014; Jain et al., 2015; 
Treutlein et al., 2014). We performed an expression time-course of AT1 and 2 cell markers from 
E15.5 to E18.5 in wild-type lungs, providing a reference for assessing the extent of alveolar 
specification/differentiation under experimental conditions. SOX2 and SOX9 are well-established 
markers of the differentiating bronchioles and tip progenitors (Fig. 1A). We observed very low, 
variable, levels of LPCAT1 (Lysophosphatidylcholine acyltransferase 1) in E15.5 lung sections 
(Fig. 1A). It is then robustly detected in tip progenitors from E16.5 and upregulated further in 
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 differentiating AT2 cells, consistent with previous reports (Chen et al., 2006; Nakanishi et al., 
2006). This makes LPCAT1 expression a useful marker of alveolar fate in distal tip progenitors. 
 
Pro-SFTPC (Surfactant protein C, pro-SPC) is expressed throughout the lung epithelium from the 
pseudoglandular stage (Wuenschell et al., 1996). We observed that it is also upregulated in the 
distal epithelial progenitors at E16.5 and subsequently in differentiating AT2 cells (Fig. 1B). The 
AT2 cell-specific transcription factor CEBPA (C/EBPα) is first detected in the nucleus of a sub-
set of distal epithelial progenitors from E16.5 and then upregulated in differentiating AT2 cells 
(Fig. 1B) as previously reported (Martis et al., 2006). Earlier, weaker, expression at E15.5 is not 
nuclear, making nuclear CEBPA a marker of alveolar fate in the distal progenitors. We also 
observed nuclear CEBPA staining in the bronchioles from E17.5 (Fig. 1B). A recent report has 
suggested that CEBPA functions redundantly with CEBPB to promote airway differentiation 
(Roos et al., 2012). We hypothesize that the airway CEBPA staining we observe reflects a second 
site of expression and therefore do not use this protein as a specific marker of developing alveolar 
fate. 
 
Similar to pro-SFTPC, the type 1 cell marker PDPN (Podoplanin, T1α) is weakly expressed in 
the distal progenitors from E15.5 and upregulated in differentiating AT1 cells (Fig. 1C,D). By 
contrast, LAMP3 (Lysosomal associated membrane protein 3) is expressed strongly in 
differentiated AT2 cells, but could not be detected robustly in distal progenitors. Rather, at E16.5 
LAMP3 is expressed at low levels in cells adjacent to the distal progenitor domain, with levels 
increasing in these cells at E17.5 (Fig. 1C,D). This makes LAMP3 useful as a marker of early 
AT2 differentiation, rather than alveolar fate within the distal progenitor population.  
 
The AT1-specific transcription factor, HOPX (Hop homeobox) could not be detected in the distal 
progenitors. However, it is robustly detected from E16.5 in cells that had exited the distal 
progenitor domain, but never in the SOX2+ differentiating bronchiolar cells (Fig. 1E,F). We 
noted that cells which have exited the distal progenitor domain by E17.5 reproducibly express 
either LPCAT1 or HOPX, but not both, suggesting that they are already starting to differentiate 
along AT1 or AT2 lineages (Fig. 1G). By contrast, cells adjacent to the distal tip at both E16.5 
and E17.5 co-express LPCAT1 and HOPX. Relative quantitation of the expression of LPCAT1, 
LAMP3, HOPX and PDPN (Fig. S1) is in agreement with our descriptions based on visual 
inspection of the images. 
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 Therefore, and consistent with recent reports, we have found that distal tip progenitors begin to 
express some markers of alveolar fate at approximately E16.5 (CEBPA, LPCAT1, PDPN protein). 
By contrast, other protein markers (LAMP3, HOPX) cannot be robustly detected until cells have 
exited the distal progenitor domain. This timing of alveolar marker expression agrees with the 
available lineage-tracing data which shows that the distal progenitor cells only produce alveolar-
fated (and not bronchiolar-fated) descendants from ~E16.5 onwards (Alanis et al., 2014; Desai et 
al., 2014; Rawlins et al., 2009a). We hypothesized that the distal progenitors respond to an 
extrinsic signalling cue to initiate the alveolar programme of development. Alternatively, the 
progenitors could be intrinsically, cell autonomously, programmed to produce alveolar progeny 
from approximately E16.5, similar to the temporal production of specific cell identities from 
neural stem/progenitors in the developing vertebrate nervous system (Livesey and Cepko, 2001). 
 
Heterochronically-grafted lung epithelial distal progenitors can respond to signals from 
their local environment and alter descendant cell fate 
To distinguish between our alternative hypotheses for extrinsic versus intrinsic control of distal 
progenitor fate we asked two related questions. Firstly, is the alveolar fate of the E16.5 SOX9+ 
distal progenitors fixed, or can they respond to local environmental cues likely from the 
mesenchyme and reactivate a bronchiolar pathway? Secondly, can bronchiolar-fated already 
differentiating SOX2+ stalk cells respond to environmental cues from the mesenchyme and 
produce alveolar-fated descendants? We microdissected pure populations of tip and stalk cells 
(Fig. S2). Then established a grafting assay to place E12.5 or E16.5 tip, or stalk, ubiquitous-
Tomato+ epithelium into the mesenchyme of unlabelled E12.5 host lungs. Hosts were cultured on 
a membrane to test the response of the grafted cells to their new environment (Fig. 2A). The 
grafts integrated into the host lungs, were surrounded by host mesenchyme, increased in size over 
time, and frequently formed a lumen (Fig. 2A’,A’’ 220/232 [95%] differentiated grafts had a 
lumen). Although the stalk samples we dissected always contained some adjacent mesenchyme 
(Fig. S2), we were unable to detect grafted mesenchymal cells at the end of the culture period 
suggesting that they did not survive. Grafts were identified based on Tomato expression and 
scored as bronchiolar, mixed (broncho-alveolar), or alveolar-fated by immunostaining alternate 
slides of serially-sectioned host lung/graft for SOX2/acetylated-tubulin (ACT) (bronchiolar 
markers), or LPCAT1/PDPN (alveolar markers). Grafts were scored as mixed if they contained 
distinct bronchiolar and alveolar regions each greater than 10 cells in size (Fig. 2B-G). Overall 
differentiation efficiency was 98% (232/237 recovered grafts had differentiated). 
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 As a positive (isochronic) control we grafted E12.5 tips into E12.5 hosts. Addition of a synthetic 
glucocorticoid, such as Dexamethasone (Dx), is necessary to produce differentiated alveolar cells 
from E12.5 lungs grown in culture. However, Dx has also been shown to promote tip progenitor 
alveolar fate (Alanis et al., 2014). We therefore cultured host lungs without Dx, or in the presence 
of Dx from culture day 4 or 5, to allow production of more mature alveolar cells but to minimise 
precocious alveolar fate specification (Fig. 2A). Previous lineage-labelling experiments showed 
that ~80% of individual distal tip cells labelled in vivo at E12.5 generate mixed clones of both 
bronchiolar and alveolar descendants (Rawlins et al., 2009a). In our isochronic control 
experiments (E12.5 tip grafted into E12.5 host), we obtained approximately 20% bronchiolar, 
40% mixed and 40% alveolar-fated grafts (Fig. 2B-D,H), consistent with the position of the graft 
influencing cell fate. By contrast, E12.5 stalks grafted into E12.5 hosts were more likely to be 
bronchiolar-fated, although mixed and alveolar-fated grafts were also observed (Figs. 2H,S3: 
p=0.0075). Moreover, these mixed and alveolar-fated stalk grafts expressed the AT2 specific 
marker LAMP3 (Fig. S3H-J). This surprising result suggests that although stalks have initiated a 
bronchiolar developmental programme, they retain some plasticity to respond to extrinsic cues 
from the local environment and alter fate. Overall the results obtained with the two growth 
conditions (no Dx, or Dx from culture day 4/5) were very similar (Fig. 2H). 
 
We next performed heterochronic grafting experiments in which E16.5 tip, or stalk, cells were 
grafted into E12.5 lungs grown without Dx, or with a short period of Dx-exposure (Fig. 2A). 
Consistent with their developmental age, the E16.5 tip grafts were more likely to produce only 
alveolar-fated descendants than their E12.5 counter-parts (Fig. 2E,F,G,I: p=0.0438). Nevertheless, 
bronchiolar-fated and mixed broncho-alveolar fated grafts were also observed showing that the 
E16.5 tip progenitors, which normally only produce alveolar descendants, can respond to local 
environmental cues and change their behaviour appropriately. The E16.5 stalk grafts behave very 
similarly to the E12.5 stalk grafts in this assay, although with somewhat less plasticity in that 
they never produce only alveolar-fated descendants (Figs. 2I, S3).  
 
We conclude that both distal progenitor cells and differentiating stalk cells can respond to their 
local environment and produce appropriate descendants. This supports the hypothesis that 
extrinsic signalling, likely from the local mesenchyme is a major determinant of lung epithelial 
progenitor cell fate. However, older distal tip and stalk cells become more refractory to external 
cues with time, presumably corresponding to increased levels of differentiation, suggesting that 
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 they have also undergone intrinsic, possibly epigenetic, changes which cell autonomously reduce 
their capacity to respond to an external signal.  
 
Glucocorticoid signalling is sufficient, but not necessary, for tip alveolar fate 
What are the extrinsic signals which promote alveolar fate in the tip progenitors? A recent report 
showed that GR signalling, likely induced by circulating glucocorticoids, was sufficient to 
promote precocious lung alveolar fate both in vitro and in vivo (Alanis et al., 2014). We therefore 
tested if GR signalling is also sufficient to promote alveolar fate in our grafting experiments. 
Host lungs were exposed to Dx throughout the culture period and the fate of the grafts 
determined (Fig. 3A-C). In these conditions almost 100% of distal tip grafts produced alveolar-
fated descendants. Moreover, attenuated PDPN+ cells with the appearance of AT1 cells 
differentiated in these grafts (Fig. 3B), consistent with sustained glucocorticoid signalling being 
necessary for AT1 differentiation. By contrast, grafted stalk cells were less likely to respond to 
the signal by producing alveolar descendants (Fig. 3C: p=0.0016). However, in the presence of 
Dx, grafted stalks were more likely to produce alveolar-fated or mixed broncho-alveolar-fated 
descendants than grafted stalks without Dx, or when Dx was added late in the culture period 
(compare Fig. 3C with 2H,I: p=0.0067). These experiments confirm the ability of GR signalling 
to promote alveolar fate. In addition, they show that the undifferentiated distal tip cells are 
completely plastic in their ability to respond to this signal. 
 
Is GR signalling necessary for tip progenitors to initiate alveolar gene expression? We observed 
that wild-type E12.5 lungs grown in vitro with Dx initiated wide-spread LPCAT1 expression by 
culture day 3. By contrast, in the absence of Dx, LPCAT1 was only robustly detected at culture 
day 5 (Fig. 3D). Thus, addition of Dx promotes/accelerates alveolar gene expression, but is not an 
absolute requirement for alveolar fate initiation to occur in vitro. However, it is possible that 
embryonic lungs can also endogenously synthesise glucocorticoids de novo (Boucher et al., 
2014). We therefore examined the timing of expression of alveolar fate markers in developing 
lungs from GR-/- embryos (Fig. 3E). We observed that, as previously published, the GR-/- lungs 
were developmentally delayed. Nevertheless, they did express markers of both tip alveolar fate 
(LPCAT1, PDPN) and alveolar differentiation (HOPX, LAMP3), albeit delayed, relative to wild-
type. This shows that GR signalling affects the timing of alveolar fate acquisition, but is not 
essential for either tip progenitor alveolar fate induction, or initial alveolar differentiation. We 
therefore hypothesized that other extrinsic signals acting prior to, or in parallel with, 
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 glucocorticoids also promote alveolar fate. Moreover, based on our in vitro grafting results we 
hypothesized that these signals would be expressed within the lung itself. 
 
Overexpression of Stat genes promotes alveolar fate/differentiation in cultured lungs 
To search for candidate signalling pathways that control alveolar fate, we isolated E11.5 and 
E17.5 distal tip cells, with a small number of their immediate progeny, and compared their 
transcriptomes using gene expression microarrays (Fig. 4A). We performed Gene Ontology (GO) 
analysis of the genes enriched in E17.5 samples and found that the most prominent GO classes 
were: Immune System Process; Immune Response; Response to External Stimulus; Response to 
wounding. Within these classes it was particularly noticeable that components of cytokine 
signalling were enriched in the older samples (Fig. 4B). Cytokine signalling is reportedly 
important for lung maturation (Ikegami et al., 2008; Matsuzaki et al., 2008; Moreno-Barriuso et 
al., 2006). We therefore tested various cell autonomous transcription factors (TFs) for their 
ability to promote alveolar fate in vitro with a focus on STAT proteins, which are important 
mediators of cytokine signalling. Adenoviruses carrying GFP, or a TF + GFP, were microinjected 
into the lumen of wild-type E12.5 lungs. This resulted in labelling of both tip and stalk cells 
within 72 hours. Lungs were then cultured for 8 days in the presence of Dx, fixed and sectioned, 
and the location of GFP+ cells scored as alveolar or bronchiolar (Fig. 4C). 
 
GFP+ cells transduced by control adenovirus were equally likely to be located in the alveoli or 
bronchioles (normalised GFP+ alveolar : bronchiolar ratio of 1; Fig. 4D, E). This was unchanged 
by NOTCH1ICD (Notch1 intracellular domain), consistent with previous in vivo results (Guseh et 
al., 2009). Similarly, CEBPA, which is expressed in E16.5 distal progenitors and also in 
bronchiolar cells from E17.5 (Fig. 1B), was unable to affect the location of GFP+ cells. By 
contrast, we found that over-expression of STAT3, 5A, or 6, or CITED2, a TF required for AT2 
differentiation (Xu et al., 2008a), was each sufficient to increase the GFP+ alveolar : bronchiolar 
ratio to ~2 (Fig. 4E). Dividing GFP+ cells were detected only rarely in our cultures (Fig. 4F) and 
we could find no evidence for effects of the transcription factors on proliferation rate. We 
confirmed that the transduced cells were differentiating to AT1 and 2 fate in our culture 
conditions (Fig. 4G,H). As an approximation to the relative production of AT2 versus AT1 cells 
in these experiments we scored the number of alveolar GFP+ cells which co-expressed high levels 
of pro-SFTPC (Fig. 4I,J). There was no evidence for a change in the percentage of (GFP,pro-
SFTPC)+ co-expressing cells when CITED2 or STATs were overexpressed. However, as a 
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 positive control for this assay, NOTCH1ICD reduced AT2 cell differentiation consistent with 
published data (Guseh et al., 2009).  
 
The effects of STAT proteins on alveolar location of GFP+ cells in these experiments could either 
be mediated through an undetected change in the differential proliferation rate between 
transduced bronchiolar versus alveolar progenitors, or through promotion of alveolar fate. 
Analysis of STAT6 protein location in wild-type embryonic lungs showed it was predominantly 
bronchiolar. We therefore made lung epithelial-specific deletions of Stat3 and Stat5 to test if they 
were required for alveolar development.  
 
Lung epithelial specific knock-out of Stat3 results in a short delay in alveolar development. 
A detailed time-course of phosphorylated-STAT3 (active, pSTAT3) expression showed it was 
undetectable at E15.5, but appeared weakly in the tip progenitors from E16.5 (arrowheads in Fig. 
5B,C) and more strongly in differentiating alveolar cells which had exited the distal progenitor 
pool (Fig. 5A-D, S4). pSTAT3 was also observed in the bronchioles, consistent with a role in 
airway differentiation (Tadokoro et al., 2014). The majority of pSTAT3+ cells were E-CAD+. 
 
We generated Nkx2.1-Cre; Stat3Δ/fx (cKO) and control Nkx2.1-Cre; Stat3+/fx, or Stat3+/fx, embryos 
to remove STAT3 specifically from the developing lung epithelium. qRT-PCR showed that Stat3 
mRNA levels were decreased in the cKO lungs compared to controls, but recombination was not 
completely efficient (Fig. 5E). pSTAT3 immunostaining in E17.5 cKO and control lungs showed 
that recombination in the cKO lungs was highly variable, with some having an almost complete 
loss of pSTAT3 and others being largely unaffected (Fig. 5F-H). Examination of reporter gene 
expression in Nkx2.1-Cre; Rosa26R-fGFP lungs gave a similar, highly variable, result (Fig. S4A).  
 
To assess a wide range of alveolar fate and differentiation markers we performed qRT-PCR from 
Stat3cKO and control lungs at E16.5 and E18.5. At E16.5, lungs from cKO mice exhibited >2-
fold decreases in the level of SftpD and Aqp5, previously reported as markers of mature AT1 and 
AT2 cells (Desai et al., 2014) (Fig. 5I,J). However, SftpD and Aqp5 levels were normal at E18.5 
and other markers did not change significantly (Fig. 5I-K, S4C). These results are suggestive of a 
short delay in alveolar differentiation. To confirm this, we performed a detailed antibody staining 
time-course in Stat3 cKO and control lungs, co-staining with pSTAT3 to assess the extent of 
recombination. We observed a modest increase in the number of SOX9+ distal tips in the cKO 
lungs at E17.5 (Fig. 5L,M; 0.1 ± 0.01, versus 0.18 ± 0.03 tips per 200 μm2, n=3 lungs), but tip 
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 number appeared normal by E18.5. Expression of the key alveolar fate and differentiation 
markers commenced at the expected times, with up-regulation in differentiating cells by E18.5 
(Fig. 5N-W, S4D-H). These subtle phenotypes are consistent with a brief developmental delay in 
the Stat3 cKO lungs. 
 
STAT5A is expressed strongly in a sub-set of distal tip progenitor cells at E16.5 (Fig. S5A). We 
generated Nkx2.1-Cre; Stat5Δ/fx (cKO) and control Nkx2.1-Cre; Stat5+/fx, or Stat5+/fx, embryos to 
remove STAT5A and B from the developing lung epithelium. Similar to Stat3, qRT-PCR 
confirmed the partial deletion of Stat5 (Fig. S5B). However, we were unable to detect any 
phenotype in the Stat5 cKO lungs (Fig. S5B-F). This indicates that STAT5 is not required for 
alveolar fate specification or differentiation. These experiments also provide useful controls 
showing that the subtle phenotypes observed in the Stat3 cKO lungs were specific to Stat3 
deletion and not a result of non-specific Cre activity. 
 
Widespread STAT3 activation accelerates lung alveolar differentiation 
We asked if STAT3 activation by ectopic ligand was sufficient to promote alveolar 
differentiation. We established a culture system in which E15.5 wild-type lung slices were 
incubated at air-liquid interface in medium containing 5% FBS. In the presence of Dx robust 
alveolar differentiation was observed after 3 days, with distinct AT1 and 2 cells arranged around 
saccular structures (Fig. 6A). To test the ability of the Interleukin 6 (IL6) family ligands, IL6 and 
LIF, to induce alveolar differentiation, individual lung slices were split and incubated with, or 
without, the cytokine for 3 days (Fig. 6B). These experiments were performed with, and without, 
Dx. Both IL6 and LIF treatment robustly activated STAT3 throughout the lung slices (Fig. 6C). 
No detectable phenotypic changes were induced by IL6 and LIF in the presence of Dx. In the 
absence of Dx, control lung slices showed low levels of LPCAT1 and LAMP3 indicating that 
alveolar fate specification had occurred. However, there was no evidence of AT2 differentiation 
or saccule formation. When either IL6 or LIF was added, in the absence of Dx, levels of the more 
specific AT2 differentiation marker LAMP3 were much higher, compared to controls (Fig. 6D; 
9/9 IL6-treated and 6/7 LIF-treated lungs in three independent experiments). HOPX and SOX9 
expression were unchanged (Fig. S6). This suggests that AT2 differentiation occurred in response 
to cytokine signalling, but the overall morphology of the slices remained immature. The effect of 
IL6 upon AT2 differentiation was consistently more potent than LIF. Oncostatin M (Osm) and its 
receptor (Osmr) were also detected in our microarray experiments (Fig. 4B), but addition of 
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 recombinant OSM to the slice cultures did not promote LAMP3 expression (Fig. S6; 0/6 OSM-
treated lungs in two independent experiments).  
 
We tested if STAT3 is required to mediate the effects of IL6 in the slice cultures. We cultured 
Stat3 cKO and sibling control lungs +/- IL6 and observed that in the absence of STAT3, LAMP3 
levels were reduced to those of control lung slices with no IL6 exposure (Fig. 6E). These results 
suggest that activation of STAT3 signalling by IL6 or LIF is sufficient to promote expression of 
mature AT2 markers, even in the absence of glucocorticoids.  
 
GR and STAT3 signalling act in parallel during alveolar development 
We considered the possibility that STAT3 and GR signalling act redundantly in alveolar 
development and that inactivation of both signalling pathways would result in a stronger 
phenotype. To test this hypothesis we cultured E12.5 Stat3 cKO and littermate control lungs for 5 
days in the absence of Dx, or in the presence of a glucocorticoid and progesterone antagonist 
Mifepristone, so that both STAT3 and GR signalling would be decreased (Fig. S7). In both 
conditions, alveolar fate markers were expressed as expected (Fig. S7) and wholemount analysis 
indicated that the transition from producing bronchiolar (SOX2+) to alveolar-fated (SOX2-) 
descendants occurred at the same time in all genotypes (Fig. S7D). These results suggest that 
STAT3 and GR signalling are not acting redundantly at these stages of alveolar development.  
 
Our ectopic ligand results (Fig. 6) are consistent with STAT3 acting downstream of GR 
signalling to mediate some of its effects. We therefore examined pSTAT3 expression in GR-/- and 
littermate control lungs. At E17.5 the GR-/- lungs had very little pSTAT3 expression consistent 
with their developmental delay (Fig. 7A). However, by E18.5 the pSTAT3 signal was 
reproducibly greater in the GR-/- lungs compared to the controls (Fig. 7B). This effect was even 
more pronounced in an independent litter, which was collected at a slightly later developmental 
stage (Fig. 7C). The increase in pSTAT3 levels could also be replicated by treating cultured lungs 
with the glucocorticoid and progesterone antagonist Mifepristone (Fig. S8A). We considered the 
hypothesis that the increase in pSTAT3 in the GR mutants was related to an increase in apoptotic 
cell death, but were unable to detect a significant increase in the levels of apoptosis measured by 
cleaved-Caspase 3 staining (Fig. S8B). Interestingly, we observed an increase in LIF protein 
levels in the GR-/- lungs, possibly partly explaining the increase in pSTAT3 (Fig. S8C).  
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 These data suggest that STAT3 signalling is not directly downstream of GR signalling in a linear 
pathway. Rather, it is likely that STAT3 and GR signalling act in parallel to promote the 
differentiation of alveolar cells, but that there is some cross-regulation between the two pathways. 
Like GR, STAT3 is not absolutely required for alveolar differentiation (Fig. 3). However, ectopic 
exposure to STAT3 activating ligands was sufficient to promote AT2 differentiation (Fig. 6). 
Activation of STAT3 signalling could be useful for promoting the maturation of human iPS cell-
derived alveolar epithelium, or for human lung regeneration. We therefore examined human 
embryonic lungs to test whether STAT3 and GR signalling are active at similar stages to mouse 
lung development (Fig. 7D). We were unable to detect epithelial pSTAT3 in the distal epithelium 
of pseudoglandular stage human lungs (post conception weeks (pcw) 11 and 14 were tested). 
However, pSTAT3 was detected strongly in the epithelium of a 17 pcw lung, which had a much 
more canalicular appearance. We therefore hypothesize that STAT3 signalling plays similar roles 
in mouse and human lung alveolar development, but further investigation is required to test this 
idea. By contrast nuclear (active) GR was slightly different between the two species. It was 
detected strongly in both mesenchyme and epithelium of E16.5 and E18.5 mouse lung as 
previously reported (Fig. S9A-C), though not at E14.5. However, nuclear GR was already present 
in the mesenchyme of 8 pcw human embryonic lungs and the distal tip epithelium of 11 and 17 
pcw samples (Fig. S9D-F). 
 
DISCUSSION 
Elucidating the cellular and molecular mechanisms that control the induction of alveolar fate in 
the distal tip progenitors of the embryonic lung, and subsequent alveolar differentiation, will be 
important for efforts to regenerate the alveolar epithelium. Our grafting experiments have 
conclusively shown that extrinsic signalling from the surrounding tissue is sufficient to control 
the fate of the progeny produced by distal lung epithelial progenitors. This is analogous to 
previous experiments which showed that mesenchymally-derived signals were sufficient to 
impose a tracheal, or lung, branching pattern on embryonic lung endoderm (Alescio and Cassini, 
1962; Shannon, 1994; Shannon et al., 1998). Interestingly, the differentiating stalk cells were 
surprisingly plastic and could be induced to produce alveolar fated descendants, even in the 
absence of exogenous Dx. The E12.5 stalks were more plastic than their more differentiated 
E16.5 counter-parts. The mechanisms underlying this plasticity, particularly the extent of any 
epigenetic changes, will be an interesting topic of future study.  
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 We present evidence that STAT3 and GR signalling are individually sufficient to promote 
alveolar differentiation and that they act in parallel during normal embryonic lung development 
(Fig. 7E). Our results also suggest that lung alveolar initiation is a highly robust process during 
which the GR and STAT3 pathways are redundant with other, yet to be identified, signalling 
modules. We observed that STAT3 and STAT5A have similar expression patterns and modest 
lung phenotypes and one possibility is that they are redundant in alveolar development, although 
we could find no evidence for compensatory upregulation/activity of either protein (Figs. S4G, 
S5F). The two genes are located adjacently on chromosome 11 and testing this hypothesis will 
require the development of additional tools for gene deletion. 
 
We focus on the initial stages of lung alveolar differentiation and show that neither STAT3 nor 
GR are absolutely required, individually or redundantly together, for this process. Nevertheless, 
experimental activation of either pathway can promote distal progenitor alveolar fate, or AT2 
differentiation, depending on timing. Glucocorticoid levels rise dramatically in the mouse foetus 
following onset of steroidogenesis at ~E15. We propose that during normal mouse lung 
development both STAT3 and GR signalling promote alveolar differentiation from ~E16.5 
onwards (Fig. 7E). GR has a greater role and is also absolutely required for the later stages of 
alveolar differentiation (Cole et al., 2004). However, both pathways are redundant with other 
signalling mechanisms at the early stages of alveolar differentiation. When GR signalling is 
disrupted we observe that signalling via STAT3 is increased, likely in an attempt to compensate. 
In support of this idea, ectopic STAT3 activity in vitro can promote AT2 differentiation in the 
absence of exogenous Dx. Interestingly, GR and STAT proteins have been reported to act 
together in multiple settings via several molecular mechanisms including joint transcriptional 
activation/repression (Engblom et al., 2007; Langlais et al., 2012) and control of nuclear 
localisation (Shin and Reich, 2013). 
 
Finally, we present evidence that STAT3 and GR signalling are active at the canalicular stage of 
normal human embryonic development, supporting the idea that their functions are conserved 
across species. It will be important to test if manipulating STAT3 can promote improved AT2 
differentiation in human lung iPS-derived cultures, or even directly in the lungs of premature 
infants. Our data show that alveolar fate determination is a highly robust process, likely involving 
additional extrinsic signalling inputs as well as STAT3 and GR. It will be important to define 
these pathways for human and mouse embryonic lungs.  
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 MATERIALS AND METHODS 
Animals 
All experiments were approved by University of Cambridge and University of Edinburgh local 
ethical review committees and conducted according to Home Office project licenses PPL80/2326, 
70/812 and 70/7874. Mouse strains Rosa26R-mT/mG (Muzumdar et al., 2007), Nr3c1Gt(ESKN92)Hgs 
(GR null) (Michailidou et al., 2008), Stat3fx (Alonzi et al., 2001), Stat5fx (Cui et al., 2004), 
Nkx2.1-Cre (Xu et al., 2008b), Id2-CreER (Rawlins et al., 2009a) and Rosa26R-fGFP (Rawlins et 
al., 2009b) have been described. Stat3Δ/+ and Stat5Δ/+ were generated by crossing floxed alleles to 
Zp3-Cre (de Vries et al., 2000). Transgenic strains were maintained on a C57Bl/6J background 
(at least N4 back-crosses, or >20 back-cross generations for GR+/-). Wild-type mice were out-
bred MF1 strain. 
 
Human Material 
The human embryonic and foetal material was provided by the Joint MRC/Wellcome Trust (grant 
099175/Z/12/Z) Human Developmental Biology Resource (www.hdbr.org), or collected at 
Addenbrooke’s Hospital (Cambridge, UK) under permission from NHS Research Ethical 
Committee (96/085). Samples used had no known genetic abnormalities. 
 
Lung cultures and manipulations  
All in vitro cultures were performed in at least 3 independent experiments unless otherwise stated. 
Mouse E12.5 lungs were cultured on Whatman Nucleopore filters 10 μm pore size (Millipore) in 
BGJ/b medium (Sigma) at 37°C, 5% CO2 up to 8 days. E15.5 lungs were cut into slices using a 
razor blade and cultured up to 3 days on filters in BGJ/b medium with 5% FBS (Gibco). 
Dexamethasone (Dx, Sigma) was used at 50 nM for E12.5 lungs and 100 nM for E15.5 slices. 
Mifepristone (Sigma) was used at 3 μM. Recombinant IL6 (R and D Systems) and LIF 
(Millipore) 10 ng/ml; recombinant OSM (R and D systems) 25 ng/ml. 
 
For grafting, tip and stalk cells were microdissected from Rosa26R-mT/mG heterozygous 
embryos using tungsten needles following 5 minutes in Dispase (Gibco, 16 U/ml final 
concentration) room temperature. Stalk cells were taken from a region of future bronchiole 2-3 
branches above the distal tip. Microdissected epithelial tips and stalks were washed in 
Phytohemagglutin PHA-P (Lectin from Phaseolus vulgaris, Sigma, 0.2 mg/ml final 
concentration) and inserted into a pocket made in the mesenchyme of a wild-type E12.5 lung on a 
filter. Grafts were always placed in approximately the centre of the host lung. 
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For adenovirus injections, E12.5 lungs were submerged in PBS and microinjected with 2x1010 
IFU (Infections Units)/ml virus mixed with trypan blue (4:1 ratio). The lumen of the branching 
tree was filled (~10 nl) by microinjecting with a Nanoject II Auto-Nanoliter Injector. Lungs were 
incubated at room temperature in PBS at least 1 hour before transfer to filter for culturing.  
 
Immunostaining 
E15.5-18.5 mouse lungs were fixed 1-2 hours in 4% paraformaldehyde at 4°C. Human lungs 
were fixed overnight. Samples were washed in PBS, sucrose protected, embedded in OCT 
(Optimum Cutting Temperature Compound, Tissue Tek) and sectioned at 8 μm. Primary 
antibodies: acetylated tubulin (mouse, 1:3000, Sigma, T7451), CEBPA (rabbit, 1:500, Santa Cruz, 
sc-61), cleaved caspase 3 (rabbit, 1:100, AbCam, ab2302), E-cadherin (rat, 1:1000, Invitrogen, 
13-1900; or mouse, 1:1000, BD, 610182), GFP (chick, 1:1000, AbCam, AB13970), GR (rabbit, 
1:100, Santa Cruz, sc-1004), HOPX (rabbit, 1:50, Santa Cruz, sc-30216, clone FL-73), KI67 
(mouse, 1:200, BD, 550609), LAMP3 (rat, 1:100, Dendritics, DDX0192, clone 1006F7.05), LIF 
(goat, 1:100, R and D Systems, AB-449-NA), LPCAT1 (rabbit, 1:500, Proteintech), PDPN 
(hamster, 1:1000, DSHB, 8.1.1), RFP (rabbit, 1:250, Rockland, 600-401-379), pro-SFTPC (rabbit, 
1:500, Millipore, AB3786), SOX2 (goat, 1:250, Santa Cruz, sc-17320, clone Y-17), SOX9 (goat, 
1:200, R and D Systems, AF3075), pSTAT3-Tyr705 (rabbit, 1:200, Cell Signalling, 9145), 
STAT5a (rabbit, 1:20, AbCam, ab7968). Antigen retrieval was by boiling in 10 mM sodium 
citrate, pH 6 for mouse anti-E-CAD, rabbit-anti-HOPX, mouse-anti-KI67, goat-anti-SOX2, 
rabbit-anti-pSTAT3. Alexa-Fluor conjugated secondary antibodies (1:2000, Life Technologies). 
DNA (Dapi, Sigma). Mounting in Fluoromount (Sigma). 
 
pSTAT3 was amplified using the TSA Plus Cyanine 3 Kit (PerkinElmer NEL744001KT). For 
double-rabbit primary staining (HOPX/LPCAT1; HOPX/pSTAT3; HOPX/STAT2; 
LPCAT1/pSTAT3) an excess (40 μg/ml) of Fab fragment donkey anti-rabbit IgG (H+L) (Jackson 
Immunoresearch, 711-007-003) was used to block the first primary. 
 
For wholemounts, cultured E12.5+5 days mouse lungs were fixed 2 hours in 4% 
paraformaldehyde at 4°C, washed in PBS with 2% non-fat milk powder and 0.2% triton and 
stained with E-cadherin (rat, 1:1000, Invitrogen, 13-1900), SOX2 (goat, 1:250, Santa Cruz, sc-
17320, clone Y-17), SOX9 (rabbit, 1:1000, Millipore, AB5532). Samples were passed through a 
glycerol series before mounting in Vectashield (Vector Labs). 
D
ev
el
o
pm
en
t •
 A
dv
an
ce
 a
rt
ic
le
  
Microscopy and image scoring 
Slides were imaged on a Zeiss AxioImager compound microscope, or Olympus FV1000 confocal 
microscope where stated. Cell numbers were scored manually in Fiji (ImageJ). Protein expression 
levels in Figure 1 were quantified using a custom macro for ImageJ (Schneider et al., 2012) 
(Gurdon Institute website) to measure the area of signal in each channel and calculate the 
proportion of the cell area containing signal for each. The DAPI channel was Gaussian blurred 
and Huang thresholded to give a representation of the cell area from the nuclear signal, other 
channels were maximum entropy thresholded (Kapur et al., 1985) to give the area containing 
signal above background. This gave a reliable metric for assessing the relative number of cells 
positive for each marker which matches our visual assessment. 
 
For grafting experiments, serial sections were cut through the entire lung and even numbered 
slides stained to show bronchiolar fate and odd-numbered for alveolar fate. Grafts were tracked in 
each section and scored as bronchiolar, alveolar, or mixed. Grafts were scored as mixed if they 
contained two clearly separated bronchiolar and alveolar regions each greater than 10 cells. 
Statistical tests were two-tailed Fisher’s exact tests. 
 
For adenovirus experiments, epithelial cells were scored based on their location and E-CAD 
staining as bronchiolar (columnar, lower intensity) or alveolar (squamous, higher intensity) and 
for the presence or absence of nuclear GFP. The normalised GFP+ alveolar : bronchiolar ratio 
was calculated by [(GFP+ alveolar epithelial cells/ all alveolar epithelial cells scored) / (GFP+ 
bronchiolar epithelial cells / all bronchiolar epithelial cells scored)]. GFP+ alveolar cells were 
later scored for the presence, or absence of pro-SFTPC in images taken with a defined exposure 
time. Images were scored by two independent investigators who were blind to the experimental 
group. Statistical tests were two-tailed t-tests with unequal variance. 
 
RT-qPCR and microarrays 
Total RNA was extracted using Qiagen RNEasy Mini Kit and cDNA was synthesised using 
Superscript III reverse transcriptase (Life Technologies). Primer sequences: Aqp5 5’-
AGGTGTGTTCAGTTGCCTTCTTC -3’ and 5’- AGATGAGGGTGGCCAGGAA-3’; Cebpa 5’-
GAGCTGAGTGAGGCTCTCATTCT-3’ and 5’-TGGGAGGCAGACGAAAAAAC-3’; Hopx 
5’-TGCCTTCGGAATGCAGATCT -3' and 5’- AGCTCAAGGGCCTGGCTC-3’; Id2 5’-
AAGGTGACCAAGATGGAAATCCT-3’ and 5’-CGATCTGCAGGTCCAAGATGT-3’; Lamp3 
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 5’-AATGTGAACGAGTGTTTGTCTGACTA-3’ and 5’-GACGACCACGATGATTGCAA-3’; 
Lpcat1 5’-TTATGGAGGAAGGTCGTGGACTT-3’ and 5’-GAAGCCGCCAGCAAACC-3’; 
SftpD 5’-AGCAGAAATGAAGAGCCTCTCG-3’ and 5’-AGGGTGCAGGTGTTGGGTAC-3’; 
Sox9 5’-GCAGCACTGGGAACAACCA-3’ and 5’-GCTCTGTCACCATAGCTTTTCTCTT-3’; 
Stat3 5’-CAGAGGGTCTCGGAAATTTAACAT-3’ and 5’-CTCCCTAAGGGTCAGGTGCTT-
3’; Stat5a 5’-TGGCTTTGCACGTTTCACA-3’ and 5’-CACCGCTTTAGCCACAAACC-3’. 
 
For microarray analysis E11.5 tip cells were manually microdissected. GFP+ E17.5 tip cells, with 
a small number of their immediate progeny, were collected by flow cytometry from Id2-CreER; 
Rosa26R-fGFP embryos exposed to 150 μg/gram mother’s body weight at E16.5. RNA was 
isolated using the Qiagen RNEasy Mini Kit, amplified and labelled using the Ovation RNA 
Amplification Kit V2 and FL-Ovation Biotin V2 (NuGEN). Hybridisation to Affymetrix mouse 
430.2 microarray chips (5 chips per condition). Data were analysed using the Bioconductor 
Package in R. Gene Ontology analysis using GOToolbox (http://genome.crg.es/GOToolBox/). 
Raw data deposited in GEO: GSE75860. 
 
Adenovirus production 
Adenovirus construction was as previously described (Zhou et al., 2008). Genes were cloned 
from E16.5 lung cDNA into a shuttle vector containing an internal ribosome entry site linked to 
nuclear GFP (IRES-nGFP), and then into the pAd/CMV/V5-DEST adenoviral vector (Invitrogen). 
High titer non-replicating virus (>1 × 1010 IFU/ml) was obtained by purification with the Fast-
Trap Adenovirus Purification and Concentration Kit (Millipore, FTAV00003). Titer was 
determined using AdEasy Viral Titer Kit (Agilent Technologies, 972500). Two isoforms of Stat3 
and Stat5a were cloned from E16.5 wild-type lungs, both were used (Stat3.1/Stat3.2; 
Stat5a.1/Stat5a.2) with indistinguishable results. 
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 Figure 1. Evolution of alveolar epithelial gene expression patterns in the developing mouse 
lung. Sections of E15.5, 16.5, 17.5 and 18.5 wild-type mouse lungs. A. Green: SOX2 
(differentiating bronchioles); red: SOX9 (tips) ; white: LPCAT1 (tip cells from E16.5, then AT2 
cells). B. Green: CEBPA (sub-set of tip cells from E16.5, then AT2 cells); red: pro-SFTPC 
(embryonic epithelium, stronger from E16.5, later specific to AT2 cells). C. Green: pro-SFTPC 
(stronger from E16.5, later specific to AT2 cells); red: LAMP3 (rare tip cells; AT2 cells); 
magenta: PDPN (tip cells from E16.5, then AT1 cells). D. green: LPCAT1 (tip cells from E16.5, 
then AT2 cells); red: LAMP3 (rare tip cells; AT2 cells); magenta: PDPN (tip cells from E16.5, 
then AT1 cells). E. Green: HOPX (stalk cells from E16.5, AT1 cells); red: SOX9 (tip cells); 
white: E-CAD (epithelial cells). F. Green: SOX2 (differentiating bronchioles); red: SOX9 (tips) ; 
white: HOPX (stalk cells from E16.5, AT1 cells). G. Green: HOPX (stalk cells from E16.5, AT1 
cells); red: LPCAT1 (tip cells from E16.5, then AT2 cells). Arrows = LPCAT1+, HOPX+ cells. 
Arrowheads = LPCAT1+, HOPX- cells. Blue: DAPI (nuclei). Dashed line = edge of lung. Bars = 
50 μm A-F; 20 μm G and insets. 
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Figure 2. Extrinsic factors are the major determinant of progenitor cell identity in the 
developing mouse lung. A. Experimental outline. Epithelial progenitors (tip or stalk) were 
microdissected from donor E12.5 or E16.5 Tomato+ (Rosa26RmT-mG/+) lungs and grafted into the 
mesenchyme of unlabelled E12.5 hosts. Hosts/grafts were cultured for 8 days without Dx, or with 
addition of 50 nM Dx at culture day 4 /5, followed by serial sectioning and staining to determine 
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 graft fate. A’,A’’. Grafts integrate into the host lung, grow and form a lumen. B-G. Sections of 
grafted lungs with alternate slides stained for green: LPCAT1 (alveolar fate); red: Tomato (graft); 
white: PDPN (basal and AT1 cells), or green: SOX2 (bronchiolar fate); RFP (graft); white: 
acetylated tubulin (cilia) to determine graft fate. Examples of tip grafts with alveolar, bronchiolar 
and mixed broncho-alveolar fate are shown. Note D/D’ and G/G’ are different sections of the 
same graft. H, I. Quantitation of graft fate/numbers of grafts analysed. Each type of graft was 
analysed in at least three independent experiments. Bars = 25 μm A’’; 100 μm B-G.  
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Figure 3. Glucocorticoid signalling is sufficient, but not essential, to specify alveolar fate. A. 
Experimental design: Tomato+ E12.5 or 16.5 tip or stalk was grafted into E12.5 host lung and 
grown with 50 nM Dx throughout culture. B. Examples of alveolar-fated tip grafts stained for 
green: LPCAT1 (alveolar fate); red: Tomato (graft); white: PDPN (basal and AT1 cells). 
Arrowheads = PDPN+ AT1 cells. C. Split bar graph showing results from B. Each type of graft 
was analysed in at least three independent experiments. D. E12.5 wild-type lungs were grown 
with, or without, Dx for up to 6 days; 2 independent experimental replicates. Note precocious 
expression of alveolar markers in the presence of Dx. Lungs cultured without Dx do express 
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 LPCAT1 from experimental day 5. Green: LPCAT1 (late tip progenitors and type 2 cells); red: 
SOX9 (tip progenitors). E, F. Sections of GR-/- and GR+/+ sibling lungs at E17.5 and E18.5 
stained for green: HOPX (AT1 cells); red: SOX9 (tip progenitors); white: E-CAD (epithelium) 
(E), and green: LPCAT1 (late tip progenitors and AT2 cells); red: LAMP3 (AT2 cells); magenta: 
PDPN (late tip progenitors and AT1 cells) (F). A total of 5 GR-/- and 5 GR+/+ sibling lungs from 3 
independent litters were observed at both E17.5 and E18.5. Blue: DAPI. Bars = 100 μm B; 50 μm 
D-F. 
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Figure 4. Overexpression of Stat genes promotes alveolar fate in distal tip progenitor cells. 
A. RNA was extracted from microdissected E11.5 distal tips. And from flow-sorted GFP+ E17.5 
tip progenitors (arrowheads), and their immediate alveolar-fated progeny (arrows), from Id2-
CreER; Rosa26R-fGFP embryos lineage-labelled by tmx injection at E16.5. B. Selected genes 
upregulated in E17.5 versus E11.5 samples. Fold change is shown in brackets. C. Experimental 
design for adenoviral-mediated overexpression of TFs in E12.5 lung epithelium. D. 
Representative images of GFP control and Stat5a adenoviral-infected lungs. Green: GFP 
(transduced cells); red: E-CAD (epithelium). All GFP+ and all E-CAD+ cells were counted 
manually. Bonchiolar (arrowheads) versus alveolar (arrows) fate was based on the location, 
morphology (columnar or squamous) and intensity of the E-CAD staining. E. Quantification of 
the ratio of GFP+ alveolar: GFP+ bronchiolar cells normalised to the total numbers of alveolar and 
bronchiolar epithelial cells scored. F. Sections of adenovirus-transduced lungs. Green: GFP 
(transduced cells); red: KI67 (proliferating cells); white (E-CAD) epithelium. Arrowheads = 
proliferating GFP+ epithelial cells. G. Green: GFP (transduced cells); red: LAMP3 (AT2); white: 
PDPN (AT1). Arrows = GFP+ AT2 cells. Arrowheads = GFP+ AT1 cells. H. Green: GFP 
(transduced cells); red: HOPX (AT1); white: E-CAD (epithelium). Arrowheads = GFP+ AT1 
cells. I. Green: GFP (transduced cells); red: pro-SFTPC (AT2 cells). Arrows = co-expressing 
cells scored as (GFP, pro-SFTPC)+. J. Quantification of the percentage of alveolar GFP+ cells 
which co-express pro-SFTPC. Blue: DAPI (nuclei). Bars = 100 μm A,D; 50 μm E,G-I. Error bars 
represent s.e.m. * p<0.05; ** p<0.01. Full experimental details are presented in the 
accompanying raw data table supplement. 
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Figure 5. Lung epithelial specific knock-out of Stat3 results in a brief delay in lung 
development. A-D. Sections of E15.5, 16.5, 17.5 and 18.5 wild-type mouse lungs stained to 
show phosphorylated (active) STAT3 protein. Red: pSTAT3; white: E-CAD (epithelium). E. RT-
qPCR for Stat3 in Nkx2.1-Cre; Stat3Δ/fx and sibling Stat3fx/+ lungs. 5 lungs of each genotype were 
collected from 3 independent litters. F-H. pSTAT3 staining in sibling control (F) and cKO (G, H) 
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 lungs shows the highly variable extent of recombination. Red: pSTAT3; white: E-CAD 
(epithelium). I-K. RT-qPCR from Nkx2.1-Cre; Stat3Δ/fx and sibling Stat3fx/+ lungs. I, J. Mature 
differentiation markers SftpD and Aqp5 at E16.5 and E18.5. K. Late progenitor/early 
differentiation markers at E16.5. L-W. Sections of Stat3 cKO and sibling lungs. L,M. E17.5. 
Green: SOX9 (tip progenitors); red: pSTAT3; white: E-CAD (epithelium). N,O. E18.5. Red: 
pSTAT3; white: PDPN (type 1 cells). P-S. Green: LPCAT1 (late tip progenitors and type 2 cells); 
red: pSTAT3; white: E-CAD (epithelium) at E16.5 (P, Q) and E18.5 (R, S). T-W. Green: HOPX 
(type 1 cells); red: pSTAT3; white: E-CAD (epithelium) at E16.5 (T, U) and E18.5 (V, W). Blue: 
DAPI. Bars = 50 μm, except 100 μm L,M. Error bars = s.e.m. * p<0.05; ** p<0.01 
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Figure 6. Ectopic IL6 family ligands result in accelerated AT2 differentiation via STAT3 
activation. A. Schematic and section of E15.5 slice culture resulting in differentiation of mature 
saccules with AT1 and 2 cells in the presence of Dx. Green: pro-SFTPC; red: PDPN. B. 
Schematic of IL6 and LIF experiments. Slices from individual lungs were split between two 
conditions for internal controls. C,D. Sections from control, IL6 and LIF-exposed wild-type lungs. 
C. Red: pSTAT3; white: E-CAD (epithelium). D. Red: LAMP3 (differentiating AT2 cells); green 
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 LPCAT1 (late tip and AT2 cells). E. Sections from control (Nkx2.1-Cre; Stat3+/fx) and mutant 
(Nkx2.1-Cre; Stat3Δ/fx) lungs +/- IL6. (N=9 Nkx2.1-Cre; Stat3Δ/fx lungs analysed in 3 independent 
experiments.) Top panels: green: pro-SFTPC; red: LAMP3. Lower panels: red: pSTAT3; white: 
E-CAD (epithelium). Blue: DAPI. Bars = 50 μm A,D; 100 μm C,E. 
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Figure 7. STAT3 and glucocorticoid function co-operatively in alveolar differentiation. A-C. 
Cryosections of GR-/- and littermate lungs. Red: pSTAT3; white: E-CAD. A. E17.5 littermates. B. 
E18.5 littermates. C. Independent E18.5 littermates. A total of 5 GR-/- and 5 GR+/+ sibling lungs 
from 3 independent litters were observed at both E17.5 and E18.5. D. Human embryonic lung 
sections from 11 and 17 pcw. Green: E-CAD (epithelium); Red: pSTAT3; blue: Dapi. Note the 
presence of mesenchymal background staining in the 11 and 17 pcw human samples. E. We 
propose that in wild-type lung development STAT3 and GR signalling work in parallel to 
promote alveolar differentiation. GR has the predominant role indicated by subtle phenotypes in 
the Stat3 mutant and impaired differentiation, but only slightly delayed alveolar specification, in 
the GR mutant. Loss of both pathways does not result in a greater phenotype, indicating that the 
ectopic pSTAT3 observed in the GR mutants is not sufficient to compensate. Nevertheless, 
ectopic activation of either pathway is sufficient to promote aspects of alveolar differentiation 
with the exact effects depending on timing. However, given that neither pathway is absolutely 
necessary for the initiation of alveolar differentiation to occur, other signalling mechanisms must 
also be involved. Bar = 100 μm A-D; 20 μm D’. 
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SUPPLEMENTAL FIGURES 
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Figure S1. Relative expression level of alveolar epithelial fate markers in normal lung 
development over time. Bar and whisker plots showing relative expression levels of alveolar 
fate markers analysed in Figure 1 in arbitrary units normalized to the total cell area sampled. 
A. LPCAT1 (raw data from images underpinning Fig. 1D). B. LAMP3 (raw data from 
images underpinning Fig 1D). C. HOPX (raw data from images underpinning Fig. 1F). D. 
PDPN (raw data from images underpinning Fig. 1D). 
Development 143: doi:10.1242/dev.134023: Supplementary information
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Figure S2. Microdissected tip and stalk cells. Examples of wholemount stained 
microdissected tip and stalk cells. Green: SOX2 (stalk/differentiating bronchioles); red: 
SOX9 (tip); white: E-CAD (epithelium); blue: DAPI (nuclei). A. E12.5 tip. B. E12.5 stalk. C. 
E16.5 tip. D. E16.5 stalk. Bars = 50 µm A,C,D; 100 µm B. 
Development 143: doi:10.1242/dev.134023: Supplementary information
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Figure S3. Grafted stalk cells can respond to the host environment and alter progeny 
cell fate. Examples of grafted stalk cells following 8 days of culture in various conditions. A-
G. Two images of each graft are shown taken from adjacent slides stained to detect alveolar 
fate: green: LPCAT1 (alveolar fate); red: Tomato fluorescence (grafted cells); white: PDPN 
(basal and type 1 cells), or bronchiolar fate: green: SOX2 (bronchiolar fate); red: RFP 
(Tomato+ graft); white: acetylated tubulin (cilia) to determine graft fate. A. E12.5 stalk, no 
Dx, bronchiolar-fated. B. E16.5 stalk, no Dx, bronchiolar-fated. C. E16.5 stalk, Dx day4/5, 
bronchiolar fated. D. E16.5 stalk, Dx day4/5, mixed broncho-alveolar fated. E. E12.5 stalk, 
Dx throughout, alveolar fated. F. E12.5 stalk, Dx throughout, mixed broncho-alveolar fated. 
G. E16.5 stalk, Dx throughout, mixed broncho-alveolar fated. H-J. Grafts are stained to detect 
alveolar markers. Green: LPCAT1 (alveolar fate); red: Tomato fluorescence (grafted cells); 
white: LAMP3 (differentiating AT2 cells). Right panel has the green channel removed to 
show the Tomato/LAMP3 co-localisation clearly. H. E12.5 stalk, Dx day4/5. I, J. E12.5 stalk, 
Dx throughout. Bars = 50 µm C left panel; 100 µm all other panels. 
Development 143: doi:10.1242/dev.134023: Supplementary information
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Error bars = s.e.m. D, E. Sections of Stat3 cKO and sibling lungs. D. Green: LPCAT1 (late 
tip and AT2 cells); red: pSTAT3; white: E-CAD (epithelium). E. Green: HOPX 
(differentiating AT1 cells); red: pSTAT3; white: E-CAD (epithelium). F: Green: Ki67 
(proliferating cells); red: E-CAD (epithelium); blue: Dapi. G. Green: STAT5; red: E-CAD 
(epithelium). H. Quantification of LPCAT1 and HOPX staining in E17.5 and E18.5 Nkx2.1-
Cre; Stat3Δ/fx and sibling Stat3fx/+ control. Mean and s.e.m. are displayed for 3 independent 
samples. Bar = 50 µm A, D, E; 25 µm B; 100 µm F, G. 
Figure S4. Alveolar maturation ultimately occurs in the Stat3 cKO lungs. A. Sections of 
E16.5 Nkx2.1-Cre; Rosa26R-fGFP lungs illustrating variation in the extent of recombination. 
Green: eGFP (reporter); red: E-CAD (epithelium). B. Section of E17.5 wild-type lung 
illustrating that pSTAT3 is predominantly seen in differentiating cells that have exited the tip. 
Green: SOX9 (tip); red: pSTAT3; white: E-CAD (epithelium). C. RT-qPCR of progenitor 
and alveolar markers from Nkx2.1-Cre; Stat3Δ/fx and sibling Stat3fx/+ control E18.5 lungs. 
Development 143: doi:10.1242/dev.134023: Supplementary information
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Figure S5. Lung epithelial specific knock-out of Stat5a/b does not result in alveolar 
differentiation phenotypes. A. Wild-type E15.5, 16.5, 17.5 lung sections. Green: E-CAD 
(epithelium); Red: STAT5A. B. RT-qPCR of Stat5a and progenitor/alveolar markers from 
Nkx2.1-Cre; Stat5Δ/fx and sibling Stat5fx/+ control lungs. Error bars = s.e.m. C-F. Sections of 
Stat5 cKO and sibling control lungs. C. E18.5. Green: LAMP3 (differentiating AT2 cells); 
red: PDPN (AT1 cells). D. E18.5. Green: LPCAT1 (AT2 cells); red: SOX9 (progenitor cells). 
E. E18.5. Green: KI67 (proliferating cells); red: E-CAD (epithelium). F. E16.5. Green: E-
CAD (epithelium); red: STAT3. At each time-point, three independent litters were collected 
and stained. Blue: Dapi. Bar = 50 µm A, E, F; 100 µm C,D. 
Development 143: doi:10.1242/dev.134023: Supplementary information
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Figure S6. Activating pSTAT3 via OSM is not sufficient to accelerate AT2 
differentiation. Sections of E15.5 lung slices cultured for 3 days +/- 10 ng/ml IL6, or +/- 25 
ng/ml OSM. A. Green: E-CAD (epithelium); red (pSTAT3). B. Green: LPCAT1 (late tip and 
AT2); red: LAMP3 (AT2). C. Green: HOPX (stalk cells from E16.5, AT1 cells); red: SOX9. 
D. Green: KI67 (proliferating cells); red: E-CAD (epithelium); Blue: Dapi. Bar = 100 µm A; 
50 µm B-D. 
Development 143: doi:10.1242/dev.134023: Supplementary information
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Figure S7. No evidence for redundant Glucocorticoid and STAT3 activity in alveolar 
development. A. Experimental scheme: E12.5 Stat3 cKO and sibling control lungs were 
cultured for 5 days in the absence of exogenous glucocorticoid. B, C. E12.5 + 5 day sections 
(n=6 Stat3 cKO lungs in two independent experiments). B. Green: LPCAT1; red: SOX9. C. 
Green: HOPX; red: SOX9; white: E-CAD. D. Confocal z-stack projections of E12.5 + 5 day 
wholemount immunostaining (n=3 Stat3 cKO lungs). Green: SOX9; red: SOX2. Blue: Dapi. 
E. Sections of wild-type E12.5 lungs cultured for 3 days in 100nm Dx (left panel), or 100 nM 
Dx with 3 µM Mifepristone (right panel). Green: GR. GR staining is reduced in the presence 
of the antagonist Mifepristone. F. Experimental scheme: E12.5 Stat3 cKO and sibling control 
lungs were cultured for 5 days in the presence of 3 µM Mifepristone, a Glucocorticoid 
inhibitor. G-I. Sections of Stat3 cKO and sibling control lungs E12.5 + 5 days culture in 
Mifepristone. Two independent Stat3 cKO lungs are shown (n=6 Stat3 cKO lungs in two 
independent experiments). G. Green: E-CAD (epithelium); red: pSTAT3. H. Green: SOX9; 
red: SOX2; white: E-CAD. I. Green: pro-SFTPC; red: LAMP3. Bar = 50 µm B, C, E; 250 µm 
D; 100 µm G-I. 
Development 143: doi:10.1242/dev.134023: Supplementary information
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Figure S8. STAT3 pathway activity in GR abrogated lungs. A. Sections of wild-type 
E12.5 lungs cultured for 3 days in 100nm Dx (left panel), or 100 nM Dx with 3 µM 
Mifepristone (right panel). Green: E-CAD (epithelium); red: pSTAT3. B, C. Sections of GR-/- 
and sibling GR+/+ control lungs. B. Red: cleaved-Caspase 3 (apoptotic cells); white: E-CAD 
(epithelium). Arrowheads mark a small number of apoptotic cells in the GR-/- lungs. C. Red: 
LIF; white: E-CAD (epithelium). Blue: Dapi. Bar = 100 µm A, B; 50 µm C. 
Development 143: doi:10.1242/dev.134023: Supplementary information
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Figure S9. GR staining in embryonic mouse and human lungs. Sections of embryonic 
lungs stained for green: GR; red: E-CAD (epithelium); blue: Dapi. A-C. Mouse E14.5, 16.8 
and 18.5. D-F. Human 8, 11 and 17 pcw. Boxed regions are blown up in B’, C’, E’, F’. 
Arrow heads = GR+ epithelial cells; arrows = GR+ mesenchymal cells.  Bar = 100 µm; 50 µm 
insets. 
Development 143: doi:10.1242/dev.134023: Supplementary information
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Figure	  4	  -­‐	  raw	  data	  table
Virus
Experiment	  
number
Lung	  
number
Total	  
bronchiolar	  
cells	  
GFP+	  
bronchiolar	  
cells
Total	  
alveolar	  
cells
GFP+	  
alveolar	  
cells
GFP+	  bronchiolar	  
cells	  /	  total	  
bronchiolar	  cells	  
(column	  E/	  
column	  D)
GFP+	  alveolar	  cells	  
/	  total	  alveolar	  
cells	  (column	  
G/column	  F)
Ratio	  GFP+	  
alveolar	  :	  
bronchiolar	  
(column	  I/column	  
J)
Mean	  ratio	  
GFP+	  
alveolar	  :	  
bronchiolar	  
Standard	  
deviation
2-­‐tailed	  T	  test	  
versus	  GFP
Total	  E-­‐CAD+	  
cells	  (column	  
D	  +	  column	  
F)
GFP+	  E-­‐CAD	  
cells	  (column	  E	  
+	  column	  G)
%	  GFP+	  E-­‐CAD	  
cells	  (column	  
P/column	  O	  
*100)
GFP ALC8 1 323 34 901 89 0.105263158 0.098779134 0.938401776 1224 123 10.04901961
ALC8 2 161 14 665 81 0.086956522 0.121804511 1.40075188 826 95 11.50121065
ALC10 3 478 29 953 79 0.060669456 0.082896118 1.366356696 1431 108 7.547169811
ALC15 4 373 108 542 144 0.289544236 0.265682657 0.917589176 915 252 27.54098361
ALC15 5 189 31 783 131 0.164021164 0.167305236 1.020022247 972 162 16.66666667
ALC15 6 258 62 595 118 0.240310078 0.198319328 0.825264299 1.078064346 0.244857 853 180 21.10199297
NOTCH ALC8 1 240 14 594 40 0.058333333 0.067340067 1.154401154 834 54 6.474820144
ALC10 2 482 24 404 22 0.049792531 0.054455446 1.093646865 886 46 5.191873589
ALC16 3 192 21 582 174 0.109375 0.298969072 2.733431517 774 195 25.19379845
ALC16 4 274 44 239 76 0.160583942 0.317991632 1.980220616 513 120 23.39181287
ALC16 5 377 64 578 74 0.169761273 0.128027682 0.754163062 955 138 14.45026178
ALC16 6 279 38 1121 169 0.136200717 0.150758252 1.106882952 1400 207 14.78571429
ALC16 7 596 88 301 34 0.147651007 0.112956811 0.765025672 1.369681691 0.72671 0.370618892 897 122 13.60089186
CEBPA ALC19 1 133 35 587 97 0.263157895 0.165247019 0.627938671 720 132 18.33333333
ALC19 2 211 83 333 167 0.393364929 0.501501502 1.274901407 544 250 45.95588235
ALC19 3 231 52 713 187 0.225108225 0.26227209 1.165093322 944 239 25.31779661
ALC19 4 368 105 524 227 0.285326087 0.433206107 1.51828426 892 332 37.21973094
ALC21 5 305 46 373 84 0.150819672 0.225201072 1.493181023 678 130 19.1740413
ALC21 6 299 40 380 63 0.133779264 0.165789474 1.239276316 679 103 15.16936672
ALC21 7 322 47 289 64 0.145962733 0.221453287 1.517190606 611 111 18.16693944
ALC21 8 398 58 441 87 0.145728643 0.197278912 1.353741497 1.273700888 0.293666 0.211391815 839 145 17.28247914
CITED2 ALC8 1 176 4 304 12 0.022727273 0.039473684 1.736842105 480 16 3.333333333
ALC8 2 465 18 970 105 0.038709677 0.108247423 2.796391753 1435 123 8.571428571
ALC17 3 58 5 1007 156 0.086206897 0.154915591 1.797020854 1065 161 15.11737089
ALC17 4 685 50 553 97 0.072992701 0.175406872 2.403074141 1238 147 11.87399031
ALC17 5 191 46 560 206 0.240837696 0.367857143 1.527406832 2.052147137 0.52842 0.002865192 751 252 33.55525965
STAT3.1 ALC14 1 390 72 1220 403 0.184615385 0.330327869 1.789275956 1610 475 29.50310559
ALC14 2 452 89 628 94 0.196902655 0.149681529 0.760180348 1080 183 16.94444444
ALC20 3 283 25 477 118 0.088339223 0.247379455 2.80033543 760 143 18.81578947
ALC20 4 148 14 254 86 0.094594595 0.338582677 3.579302587 402 100 24.87562189
ALC20 5 85 15 396 107 0.176470588 0.27020202 1.531144781 481 122 25.36382536
ALC20 6 61 11 322 110 0.180327869 0.341614907 1.894409938 383 121 31.5926893
ALC22 7 283 25 477 118 0.088339223 0.247379455 2.80033543 760 143 18.81578947
ALC22 8 148 14 254 86 0.094594595 0.338582677 3.579302587 2.341785882 1.010478 0.01169454 402 100 24.87562189
STAT3.2 ALC20 1 219 26 466 107 0.118721461 0.229613734 1.934054143 685 133 19.41605839
ALC20 2 259 15 292 44 0.057915058 0.150684932 2.601826484 551 59 10.70780399
ALC22 3 318 24 475 86 0.075471698 0.181052632 2.398947368 793 110 13.87137453
ALC22 4 812 54 335 45 0.066502463 0.134328358 2.019900498 1147 99 8.631211857
ALC22 5 420 36 474 82 0.085714286 0.172995781 2.018284107 2.19460252 0.290294 0.000142186 894 118 13.19910515
STAT5A.1 ALC12 1 409 7 739 43 0.017114914 0.058186739 3.399768026 1148 50 4.355400697
ALC12 2 100 1 539 19 0.01 0.035250464 3.525046382 639 20 3.129890454
ALC12 3 302 9 971 43 0.029801325 0.044284243 1.485982378 1273 52 4.084838963
ALC17 4 664 88 912 270 0.13253012 0.296052632 2.233851675 1576 358 22.71573604
ALC17 5 367 53 1034 244 0.144414169 0.235976789 1.634027955 1401 297 21.19914347
ALC17 6 190 12 557 76 0.063157895 0.136445242 2.160383004 2.406509903 0.868582 0.004801348 747 88 11.78045515
STAT5A.2 ALC12 1 570 23 808 71 0.040350877 0.087871287 2.177679724 1378 94 6.821480406
ALC12 2 388 15 489 64 0.038659794 0.130879346 3.385412406 877 79 9.007981756
ALC18 3 615 89 942 261 0.144715447 0.277070064 1.914585272 1557 350 22.47912653
ALC18 4 617 98 561 223 0.158833063 0.397504456 2.502655608 2.495083253 0.640434 0.001027725 1178 321 27.24957555
STAT6 ALC19 1 97 12 476 105 0.12371134 0.220588235 1.783088235 573 117 20.41884817
ALC19 2 182 47 345 103 0.258241758 0.298550725 1.15609004 527 150 28.4629981
ALC19 3 452 56 542 115 0.123893805 0.212177122 1.712572483 994 171 17.20321932
ALC19 4 313 20 416 64 0.063897764 0.153846154 2.407692308 1.764860766 0.512152 0.020296067 729 84 11.52263374
Development 143: doi:10.1242/dev.134023: Supplementary information
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